Skip to content

App-based Cognitive Training at Home

Effects of App-based Cognitive Training on Cognition in Community Dwelling Elderly Using: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03494699
Acronym
ACTH
Enrollment
400
Registered
2018-04-11
Start date
2018-03-22
Completion date
2019-12-01
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Aged

Brief summary

This randomized controlled trial is for investigating the effects of multidisciplinary intervention program on cognition and activity of daily living ability in community dwelling healthy elderly. The intervention consists of cognitive group training every month, daily home cognitive training using cognitive training smartphone application, record of weekly physical activity and body weight and feedback program, and alcohol and smoking cessation monitoring and feedback program. Among these interventions, app-based cognitive training at home is the major intervention in this study. The total duration of intervention is 1 year, and the tablet-based cognitive screening test and the patient-reported questionnaires to evaluate subjective memory decline, quality of life, depression, and activity of daily living are used for outcome measures.

Interventions

BEHAVIORALMultidisciplinary prevention

group cognitive training (every month) App-based Cognitive Training at Home (using smartphone application) physical activity/body weight/smoking & alcohol cessation monitoring and feedback

Sponsors

Gangnam Community Health Center
CollaboratorOTHER
Gangnam-gu Center for Dementia
CollaboratorUNKNOWN
Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* literate * education years \>= 6 years * not demented * mini-mental status examination \>= 24 * android cellular phone users * no significant decline in activities of daily living (Korea- Instrumental Activities of Daily Living =\<5)

Exclusion criteria

* Who has a history of major cardiovascular diseases within 3 months of study enrollment (ex. myocardial infarction, stroke) * Who has current illnesses that could possibly affect cognition or with anticipated life expectancy of less than 2 years (ex. end stage cancer, on chemotherapy) * Who has a severe hearing difficulty or visual disturbance * Who has a limitation in communication * Who was diagnosed with dementia * Who has a plan for immigration or move in 1.5 years after study enrollment * Who underwent a cognitive training within 6 months of study enrollment

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Cognition at 6 monthBaseline, 6monthsTable-based cognitive screening test score
Change from Baseline Cognition at 1 yearBaseline, 1yearTable-based cognitive screening test score

Secondary

MeasureTime frameDescription
Change in anxietyBaseline, 6months, 1yearGeriatric Anxiety Inventory
Change in StressBaseline, 6months, 1yearKorean version of recognized stress scale
Change in Subjective memoryBaseline, 6months, 1yearMultifactorial Memory Questionaire
Change in Quality of life measuresBaseline, 6months, 1yearQuality of life questionnaire
Change in Dementia Screening Questionnaire scoreBaseline, 6months, 1yearKorean Dementia Screening Questionnaire
Change in Prospective and retrospective memoryBaseline, 6months, 1yearProspective and retrospective memory questionnaire
Change in MasteryBaseline, 6months, 1yearMastery questionnaire
Change in Activities of Daily LivingBaseline, 6months, 1yearKorean version of Bayer ADL (Bayer Activities of Daily Living)
Change in DepressionBaseline, 6months, 1yearGeriatric depression scale

Countries

South Korea

Contacts

Primary ContactDuk L. Na, MD.PhD.
dl1018.na@samsung.com82234102378
Backup ContactHyemin Jang, MD
hmjang57@gmail.com821063282876

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026